Session ID: 

Pharma Partnerships with Innovative Start Ups

11:35am - 12:15pm Monday, March 9
Orlando - Hyatt Regency
Hyatt - Orlando Ballroom L
Extra Fee


Pharma companies attend HIMSS for various reasons, but many walk the show floor searching for innovative start-ups with solutions capable of delivering better outcomes and a competitive advantage in the marketplace.

In this session, Naomi Fried, a respected industry thought leader, joins with Eli Lilly and Company’s Director, Digital Health Innovation James Parshall to explore what pharma companies look for in an innovative start-up with potentially disruptive technology.

Key discussion points include:

  • What did Lilly learn last year from its first open Innovation Challenge?

  • What are good expectations for pharma and start-ups to have for each other?

  • What might a successful collaboration look like?

This session will get to the heart of what success looks like for all: patients, pharma, and start-up.

This session is part of a special program called HIMSS20 Pharma Forum. Extra fees and separate registration is required.


Director, Digital Health External Innovation,
Eli Lilly and Company
Chief Executive Officer,
Health Innovation Strategies


Life Sciences Professional
Pharmacy Professional